Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Coherent's Epic

This article was originally published in The Gray Sheet

Executive Summary

Coherent's Epic: Laser system manufacturer plans worldwide launch in January of its portable "three-in-one" Nd:Yag laser system for use in posterior capsulotomy and photocoagulation following 510(k) clearance Dec. 9, the firm states. Use of the device for selective laser trabeculoplasty is still being studied, the Santa Clara, California firm notes. Epic "provides a unique combination of laser wavelength options that makes it possible to treat the three most common eye diseases -- glaucoma, secondary cataracts, and diabetic retinopathy -- with a single laser," states Kevin Connors, president and general manager of Coherent Medical Group, in a Dec. 18 release...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel